The health care sector's ties to the increasingly unpopular Affordable Care Act, plus an uncertain U.S. presidential picture, give some financial experts pause.
Most of the 11 S&P sectors have declining momentum, the charts show.
Johnson & Johnson is undergoing a transformation in its product portfolio. These three ETFs may benefit if investors are excited about third-quarter results.
Most of the 11 S&P sectors have negative weekly charts. Here's this week's scorecard.